SCHEMBL20581201

SCHEMBL20581201

Cn1cc(NC(=O)O)nc1C(=O)Nc1ccc2oc(C(=O)N3CCSCC3)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.41
▸ SYK P43405 1/20 0.40
▸ ALDH1A1 P00352 7/20 0.39
▸ RAB9A P51151 6/20 0.39
▸ NPC1 O15118 5/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ MAPT P10636 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TSHR P16473 2/20 0.37
▸ USP2 O75604 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NTSR1 P30989 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ POLB P06746 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18976140 0.88 HRH4 (0.38) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL20581440 0.84 HRH4 (0.44) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL18976466 0.74 HRAS (0.41) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL20580855 0.74 RAB9A (0.50) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL20580879 0.73 RAB9A (0.51) HRH4SYKALDH1A1RAB9ANPC1
SCHEMBL18976128 0.72 MAPT (0.47) ALDH1A1RAB9AHPGDMAPTLMNA
SCHEMBL18976199 0.68 HRH4 (0.48) HRH4ALDH1A1RAB9ANPC1HPGD
SCHEMBL20580941 0.67 JAK1 (0.41) ALDH1A1RAB9ANPC1HPGDMAPT
SCHEMBL16693618 0.67 BACE1 (0.48) ALDH1A1RAB9ANPC1HSD17B10HPGD
SCHEMBL20580922 0.66 LMNA (0.45) SYKRAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS Secretary of State for Health and Social Care (GB) 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS HRH4 13/4885SYK 3347/4885ALDH1A1 2651/4885
US-20180354958-A1 PBD ANTIBACTERIAL AGENTS OPRD1, XDH, SBDS HRH4 13/4885SYK 3347/4885ALDH1A1 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback